Schedule 13G ownership disclosure
Protagonist Therapeutics Inc
Security class unavailable · CUSIP: 74366E102
Event date: 2019-06-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,499,129
- Percent of class
- 6.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-035942
- Form type
- SC 13G
- Filer
- Protagonist Therapeutics, Inc
- CIK
- CIK 1377121
- Filed
- Jun 17, 2019
- Reporting period
- Jun 07, 2019
- Description
- Schedule 13G beneficial ownership